Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

16.40
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
11.85
Today|||52-Week Range
19.90
+17.56%
Year-to-Date

Today’s Trading

Previous close16.40
Today’s open15.20
Day’s range14.89 - 17.35
Volume2,336,034
Average volume (3 months)879,295
Market cap$1.3B
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-351.16%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...0.000.00%
XLRNAcceleron Pharma Inc0.000.00%
----
EPZMEpizyme Inc0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer &
Chief Scientific Officer
Ganesh Venkataraman Kaundinya
Corporate headquarters
Cambridge, Massachusetts

Forecasts